Cited by 123Lipid metabolism and biosynthesisPeroxisome Proliferator-Activated ReceptorsMetabolism and Genetic Disorders

Cyclic AMP and fatty acids increase carnitine palmitoyltransferase I gene transcription in cultured fetal rat hepatocytes

Open access
Chatelain, Florence, Kohl, Claude, Esser, Victoria, Mcgarry, J. Denis, Girard, Jean, Pegorier, Jean‐Paul·1996·European Journal of Biochemistry

Abstract

In the rat, the gene for liver mitochondrial carnitine palmitoyltransferase I (CPT I), though dormant prior to birth, is rapidly activated postnatally. We sought to elucidate which hormonal and/or nutritional factors might be responsible for this induction. In cultured hepatocytes from 20-day-old rat fetus, the concentration of CPT I mRNA, which initially was very low, increased dramatically in a dose-dependent manner after exposure of the cells to dibutyryl cAMP (Bt2cAMP). Similar results were obtained when long-chain fatty acids (LCFA), but not medium-chain fatty acids, were added to the culture medium. The effects of Bt2cAMP and LCFA were antagonized by insulin, also dose dependently. In contrast, CPT II gene expression, which was already high in fetal hepatocytes, was unaffected by any of the above manipulations. Bt2cAMP stimulated CPT I gene expression even when endogenous triacylglycerol breakdown was suppressed by lysosomotropic agents suggesting that the actions of cAMP and LCFA were distinct. Moreover, half-maximal concentrations of Bt2cAMP and linoleate produced an additive effect CPT I mRNA accumulation. While linoleate and Bt2cAMP stimulated CPT I gene transcription by twofold and fourfold, respectively, the fatty acid also increased the half-life of CPT I mRNA (50%). When hepatocytes were cultured in the presence of 2-bromopalmitate, (which is readily converted by cells into its non-metabolizable CoA ester) CPT I mRNA accumulation was higher than that observed with oleate or linoleate. Similarly, the CPT I inhibitor, tetradecylglycidate, which at a concentration of 20 microM did not itself influence the CPT I mRNA level, enhanced the stimulatory effect of linoleate. The implication is that induction of the CPT I message by LCFA does not require mitochondrial metabolism of these substrates; however, formation of their CoA esters is a necessary step. Unlike linoleate, the peroxisome proliferator, clofibrate, increased both CPT I and CPT II mRNA levels and neither effect was offset by insulin. It thus appears that the mechanism of action of LCFA differs from that utilized by clofibrate, which presumably works through the peroxisome proliferator activated receptor. We conclude that the rapid increase in hepatic CPT I mRNA level that accompanies the fetal to neonatal transition in the rat is triggered by the reciprocal change in circulating insulin and LCFA concentrations, coupled with elevation of the liver content of cAMP.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1432-1033.1996.00789.x

Cites

60 of 60 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Sensing of free fatty acid availability within the cell primarily occurs through peroxisome proliferator-activated receptors, which function as fatty acid-activated transcription factors that drive the expression of CPT1.

    “Sensing of free fatty acid availability within the cell primarily occurs through peroxisome proliferator–activated receptors, which function as fatty acid–activated transcription factors that drive the expression of CPT1 (64, 65).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 3

  1. Zandomeni, R., Mittleman, B., Bunick, D., Ackerman, S. ik Wcin- rnann, R. (1 982) Mechanism o l action oi' dichloro-F-rho- luranosylbenzirnidazole: effect on in vitro transcription, Proc. Not1 A w d . Sci. USA 7.9. 3 167 -7 170.
  2. Prip-Buus, C., Pkgorier, J. P., Duic, P. H., Kohl. C. 62 Girard, J. ( I9YO) Evidence that thc sensitivity of carnitinc palriiitoyltransler- 193, 2 6 5 2 7 5 . 14321033, 1996, 3, m e T to inhibition by malonyl-CoA is an important site ofrcgula- tion of hepatic fatty acid oxidation in the fetal and newborn rabbit. Pcrinatal dcvelopment and eft'ects of pancreatic hormones in cul- tured tabbit hepatocytes, Biochem. ,I. 269, 409-415. · DOI
  3. Bremer, J. 8~ Osmundsen, H. (1984) Fatty acid oxidation and its regulation, in Fatty acid rrirtaholism and its re,qulation (Numa. S., ed.) pp. 113-154, Elsevier Science Publishers H. V., Ainstcr- dam.

Cited by

Sorted by citations

Authors
Chatelain, F., Kohl, C., Esser, V., Mcgarry, J. D., Girard, J., & Pegorier, J.
Affiliations
  • Centre National de la Recherche Scientifique (FR)
  • The University of Texas Southwestern Medical Center (US)
Venue
European Journal of Biochemistry
Publisher
Wiley
Published
1996-02
Volume
235
Issue
3
Pages
789-798
ISSN
  • 0014-2956 (ISSN-L)
  • 1432-1033
OpenAlex
W2070973234
Cited by
123
References
60
Citations by year
2025: 1 · 2023: 3 · 2022: 1 · 2020: 1 · 2019: 2 · 2018: 3 · 2017: 3 · 2016: 2 · 2015: 3 · 2014: 1 · 2013: 1 · 2012: 3
FWCI
7.53
Type
journal article
Language
en
Open access
Locations
  • European Journal of Biochemistry (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Institute of Diabetes and Digestive and Kidney Diseases (DK 18573)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
Keywords
carnitine palmitoyltransferase 1, dibutyryl cyclic AMP, long-chain fatty acids, linoleate, insulin, fetal to adult transition, peroxisome proliferator-activated receptors, clofibrate
MeSH terms
Animals, Carnitine O-Palmitoyltransferase, Cells, Cultured, Clofibrate, Bucladesine, Fatty Acids, Female, Fetus, Isoenzymes, Mitochondria, Liver, RNA, Messenger, Transcription, Genetic, Rats, Wistar, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review